Patients with invasive pneumococcal disease (IPD) have an increased risk for acute myocardial infarction (AMI), with the elevated risk persisting for one year, according to a study published online Feb. 8 in Clinical Infectious ...
Mar 27, 2023
0
7
Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces cardiovascular deaths, strokes, and other adverse outcomes by 20% compared to usual care. The beneficial effects of early rhythm ...
Mar 27, 2023
0
5
Research findings from Rutgers, the University of Michigan, the University of Texas Southwestern, and the Medical University of South Carolina could save lives by enabling faster and more accurate identification of hospitalized ...
Mar 27, 2023
0
13
Babesiosis, a tick-borne disease, is endemic in 10 U.S. states, according to a March report by the Atlanta-based Centers for Disease Control and Prevention (CDC). The parasitic disease primarily occurs within the Northeast ...
Mar 22, 2023
0
21
Individuals who are obese may be more susceptible to severe COVID-19 because of a poorer inflammatory immune response, say Cambridge scientists.
Mar 20, 2023
0
52
With the combination of the drugs Venetoclax and 5-Azacitidine, a new, effective and more tolerable alternative to chemotherapy for the treatment of AML has been available for several years. But for some patients, the drug ...
Mar 16, 2023
0
1
Greater Manchester Researchers have shown for the first time that malfunctioning behavior of a type of immune cell is linked to specific symptoms of long- COVID.
Mar 16, 2023
0
13
Consuming a diet rich in vitamin A or its analogs may help prevent children and young adults with acute lymphoblastic leukemia (ALL) reduce their risk of developing painful pancreas inflammation during chemotherapy treatment.
Mar 15, 2023
0
83
Acute gastroenteritis afflicts adults of all ages, causing significant suffering and inflicting significant costs on the American healthcare system. A new study encompassing nearly 40,000 hospital visits from a geographically ...
Mar 15, 2023
0
5
Researchers from The University of Texas MD Anderson Cancer Center showed that inhibiting menin with revumenib, previously known as SNDX-5613, yielded encouraging responses for advanced acute leukemias with KMT2A rearrangements ...
Mar 15, 2023
0
27
